Download MendeleySmall-molecule inhibition of the archetypal UbiB protein COQ8.
Murray, N.H., Asquith, C.R.M., Fang, Z., East, M.P., Ptak, N., Smith, R.W., Vasta, J.D., Zimprich, C.A., Corona, C.R., Robers, M.B., Johnson, G.L., Bingman, C.A., Pagliarini, D.J.(2023) Nat Chem Biol 19: 230-238
- PubMed: 36302899
- DOI: https://doi.org/10.1038/s41589-022-01168-3
- Primary Citation of Related Structures:
7UDP, 7UDQ - PubMed Abstract:
Small-molecule tools have enabled mechanistic investigations and therapeutic targeting of the protein kinase-like (PKL) superfamily. However, such tools are still lacking for many PKL members, including the highly conserved and disease-related UbiB family. Here, we sought to develop and characterize an inhibitor for the archetypal UbiB member COQ8, whose function is essential for coenzyme Q (CoQ) biosynthesis. Guided by crystallography, activity assays and cellular CoQ measurements, we repurposed the 4-anilinoquinoline scaffold to selectively inhibit human COQ8A in cells. Our chemical tool promises to lend mechanistic insights into the activities of these widespread and understudied proteins and to offer potential therapeutic strategies for human diseases connected to their dysfunction.
Organizational Affiliation:
Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.
